Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...

Global Peripheral Artery Disease Market is valued at approximately USD 4.5 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2024-2032.

Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a ...

CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease: Bagsværd, Denmark Wednesday, June 25, 2025, 15:00 Hrs [IST] Novo Nordisk, a leading global h ...

Leg amputation rates caused by arterial disease are four times as high in the most disadvantaged areas in England.

Understand Peripheral Artery Disease (PAD) and its link with hypertension. Learn about the causes, symptoms, and risks associated with PAD. Know how managing hypertension can help mitigate PAD risks.

Leg amputation rates caused by arterial disease are four times as high in the most disadvantaged areas in England. The study, ...

With a distribution agreement in place and an option to acquire Contego Medical, Medtronic’s peripheral vascular division ki ...